- Report
- September 2025
- 250 Pages
Global
From €3934EUR$4,490USD£3,395GBP
- Report
- February 2026
- 268 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- February 2026
- 377 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- February 2026
- 273 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- February 2026
- 381 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- February 2026
- 395 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- February 2026
- 369 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- February 2026
- 372 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- February 2026
- 386 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- February 2026
- 384 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- February 2026
- 362 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- February 2026
- 477 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- February 2026
- 276 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- February 2026
- 372 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- February 2026
- 194 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- February 2026
- 180 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- February 2026
- 193 Pages
Global
From €5125EUR$5,850USD£4,423GBP
- Report
- September 2025
- 250 Pages
Global
From €3934EUR$4,490USD£3,395GBP
- Report
- September 2025
- 250 Pages
Global
From €3934EUR$4,490USD£3,395GBP
- Report
- September 2025
- 250 Pages
Global
From €3934EUR$4,490USD£3,395GBP

Anticonvulsants are a class of drugs used to treat seizures and other neurological disorders. They work by reducing the abnormal electrical activity in the brain that causes seizures. Anticonvulsants are used to treat a variety of conditions, including epilepsy, bipolar disorder, and neuropathic pain. They are also used to prevent seizures in people with certain types of brain injuries. Anticonvulsants are part of the larger class of Central Nervous System (CNS) drugs, which also includes antidepressants, antipsychotics, and anxiolytics.
The anticonvulsant market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Other companies include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more